EDSA Edesa Biotech, Inc. - Common Shares
NASDAQ · Biotechnology · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 13, 2026
$3.86
· of 52w range
· above low
· to high
$0.7652w low
$20.3252w high
Market Cap (MRQ)
$37M
your badges
52W Range
$1–$20
Analyst Rating
BUY
Price Target
$16
P/E
·
ROE
-51.3%
Net Profit Margin
·
Your badge strip is empty — pin a metric anywhere on this page.
EDSA Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$3.86
Market Cap (MRQ)
$37M
ROE
-51.3%
52W Range
$1–$20
EDSA Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| Oct. 11, 2023 | 1-for-7 | Reverse |
| June 10, 2019 | 1-for-6 | Reverse |
| May 7, 2018 | 1-for-7 | Reverse |
| Sept. 2, 2015 | 1-for-10 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
Revenue·2017-09-30 → 2021-09-30
Free Cash Flow·2017-09-30 → 2023-09-30
Net margin·2017-09-30 → 2020-09-30
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | EDSA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/S | 250.6 | · | · | · | |
| P/B (MRQ) | 4.25Y avg ≈18.5 | ≈18.5 | · | · | |
| Price / Cash Flow | -3.85Y avg ≈-18.1 | ≈-18.1 | · | · | |
| Price / Tangible Book (MRQ) | 5.45Y avg ≈20.8 | ≈20.8 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | EDSA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| ROA | -82.9%5Y avg ≈-90.0% | ≈-90.0% | · | · | |
| ROE | -51.3%5Y avg ≈-85.4% | ≈-85.4% | · | · | |
| ROIC | -63.5% | · | · | · |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | EDSA | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 2.85Y avg ≈7.5 | ≈7.5 | · | · | |
| Quick Ratio | 10.05Y avg ≈6.9 | ≈6.9 | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-8.4%
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| Sept. 30, 2026 | $-0.60 | $-0.59 | -1.4% | |
| June 30, 2026 | Aug 13, 2026 | $-0.60 | $-0.59 | -1.4% |
| March 31, 2026 | May 14, 2026 | $-0.49 | $-0.27 | -84.8% |
| Dec. 31, 2025 | $-0.28 | $-0.46 | 39.0% | |
| Sept. 30, 2025 | $-0.32 | $-0.27 | -17.6% | |
| June 30, 2025 | $-0.25 | $-0.27 | 6.9% | |
| March 31, 2025 | $-0.30 | $-0.30 | 0.30% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | · | · | · | · | $0 | $328.8K | · | $211.8K | $228.3K | $1M | $758.7K | · | |
| Cost of Revenue | · | · | · | · | $0 | $17.6K | · | $133.3K | $250.0K | $818.6K | $580.8K | · | |
| R&D Expense | $4M | $3M | $5M | $13M | $18M | $3M | · | $2M | $2M | $2M | $1M | · | |
| SG&A Expense | $4M | $4M | $4M | $5M | $6M | $3M | · | $3M | $3M | $3M | $3M | · | |
| Operating Expenses | · | · | · | · | · | $7M | · | $5M | $5M | $6M | $5M | · | |
| Operating Income | $-8M | $-7M | $-9M | $-18M | $-24M | $-6M | · | $-5M | $-5M | $-5M | $-4M | · | |
| Interest Income | · | · | · | · | · | $37.8K | · | $75.2K | $32.7K | $24.6K | $54.6K | · | |
| Other Non-op | $726.8K | $845.5K | $849.1K | $822.7K | $10M | $37.4K | · | $40.1K | $194.7K | $-110.5K | $2M | · | |
| Pretax Income | $-7M | $-6M | $-8M | $-18M | $-13M | · | · | $-5M | $-5M | $-5M | $-3M | · | |
| Income Tax | $800 | $800 | $800 | $800 | $800 | $800 | · | $800 | $800 | $7.2K | $36.8K | · | |
| Net Income | $-7M | $-6M | $-8M | $-18M | $-13M | $-6M | · | $-5M | $-5M | $-5M | $-3M | · | |
| EPS (Basic) | $-1.27 | $-1.93 | $-2.93 | · | · | · | · | · | · | $-0.57 | $-0.36 | · | |
| EPS (Diluted) | · | · | · | · | · | · | · | · | · | $-0.57 | $-0.36 | · | |
| Shares (Basic) | 5,676,708 | 3,197,423 | 2,858,929 | · | · | · | · | · | · | 8,826,312 | 7,956,962 | · | |
| Shares (Diluted) | · | · | · | · | · | · | · | · | · | 8,826,312 | 7,956,962 | · | |
| EBITDA | $-8M | · | $-9M | · | $-24M | $-6M | · | $-5M | $-5M | $-5M | $159.5K | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $11M | $1M | $5M | $7M | $8M | $7M | $5M | $4M | $5M | $7M | $4M | $9M | |
| Short-term Investments | · | · | · | · | · | · | $0 | $6M | $2M | $4M | $5M | $5M | |
| Receivables | · | · | · | · | $3M | $87.4K | $217.1K | $41.2K | $1.3K | $85.8K | $157.6K | $44.2K | |
| Inventory | · | · | · | · | · | · | · | $224.3K | $68.1K | $249.4K | $557.3K | $34.9K | |
| Prepaid Expense | $77.8K | $367.4K | $448.9K | $745.5K | $948.6K | $802.9K | $397.0K | $86.9K | $123.7K | $358.7K | $181.1K | $125.8K | |
| Current Assets | $12M | $2M | $6M | $9M | $12M | $8M | $6M | $11M | $7M | $12M | $10M | $14M | |
| PP&E (Net) | · | $0 | $8.7K | $12.7K | $15.0K | $14.8K | $73.1K | $1M | $879.5K | $756.1K | $503.4K | $388.3K | |
| PP&E (Gross) | · | $52.5K | $52.5K | $52.2K | $48.8K | $40.3K | $50.8K | · | · | · | · | $906.6K | |
| Accum. Depreciation | · | $52.5K | $43.8K | $39.5K | $33.9K | $25.5K | $29.2K | $1M | $969.4K | $793.1K | $643.5K | $518.3K | |
| Intangibles | $2M | $2M | $2M | $2M | $2M | $2M | $0 | · | · | · | · | · | |
| Total Assets | $14M | $4M | $9M | $12M | $15M | $11M | $6M | $12M | $8M | $13M | $10M | $15M | |
| Accounts Payable | $1M | $2M | $2M | $2M | $1M | $1M | $461.6K | $493.4K | $320.9K | $623.6K | $656.7K | $585.0K | |
| Current Liabilities | $1M | $2M | $2M | $2M | $1M | $2M | $461.6K | $493.4K | $320.9K | $623.6K | $2M | $672.2K | |
| Capital Leases | · | $0 | $19.8K | $0 | $20.5K | $94.5K | $0 | · | · | · | · | · | |
| Total Liabilities | · | $2M | $2M | $2M | $2M | $2M | $461.6K | · | · | · | $2M | $4M | |
| Common Stock | $55M | $47M | $47M | $42M | $35M | $19M | $12M | $57M | $48M | $47M | $38M | $38M | |
| Paid-in Capital | $15M | $14M | $13M | $11M | $5M | $2M | $327.8K | · | · | · | · | · | |
| Retained Earnings | $-66M | $-59M | $-52M | $-44M | $-26M | $-13M | $-7M | $-50M | $-45M | $-40M | $-35M | $-32M | |
| AOCI | $-165.8K | $-242.6K | $-214.6K | $-213.6K | $-205.3K | $-287.2K | $-342.1K | · | · | · | · | · | |
| Stockholders' Equity | $12M | $2M | $7M | $9M | $13M | $7M | $5M | $4M | $7M | $12M | $8M | $10M | |
| Liabilities + Equity | $14M | $4M | $9M | $12M | $15M | $11M | $6M | $12M | $8M | $13M | $10M | $15M | |
| Shares Outstanding | 7,141,783 | 3,247,389 | 3,075,473 | 2,380,280 | 13,295,403 | 9,615,119 | 7,504,468 | 5,330,715 | 1,502,870 | 10,136,258 | 7,984,758 | 7,941,985 |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $119.3K | $186.0K | $183.5K | $118.2K | $118.8K | $57.6K | · | $188.0K | $179.3K | $149.6K | $159.5K | · | |
| Stock-based Comp | $729.6K | $537.5K | $1M | $2M | $3M | $598.4K | · | $154.3K | $115.5K | $259.4K | $267.2K | · | |
| Amort. of Intangibles | $101.17B | $101.17B | $101.17B | $1.01B | · | $45.9K | · | · | · | · | · | · | |
| Other Non-cash | $-985.7K | · | · | · | · | · | · | · | $36.1K | $111.5K | $-2M | · | |
| Operating Cash Flow | $-7M | $-5M | $-7M | $-12M | $-14M | $-5M | · | $-5M | $-5M | $-5M | $-4M | · | |
| CapEx | · | · | $0 | $5.7K | $6.1K | $4.9K | · | $382.8K | $302.7K | $402.3K | $274.6K | · | |
| Investing Cash Flow | · | · | $0 | $-5.7K | $-6.1K | $19.1K | · | $-4M | $2M | $557.4K | $122.5K | · | |
| Stock Issued | $8M | $729.4K | $4M | $12M | $42.0K | $4M | · | $5M | $0 | $6M | $0 | · | |
| Net Stock Activity | $8M | · | $4M | · | $1M | $4M | · | $5M | $0 | $6M | · | · | |
| Financing Cash Flow | $17M | $592.0K | $5M | $12M | $14M | $7M | · | $9M | $0 | $7M | $106.8K | · | |
| Net Change in Cash | $10M | $-4M | $-2M | $-748.3K | $625.6K | $2M | · | $-345.4K | $-3M | $3M | $-5M | · | |
| Taxes Paid | · | · | · | · | · | · | · | $800 | $800 | $7.2K | $36.8K | · | |
| Free Cash Flow | · | · | $-7M | · | $-14M | $-5M | · | $-5M | $-5M | $-5M | $-5M | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | · | · | -1946.7% | · | -2397.1% | -2288.6% | -386.0% | · | · | |
| Net Margin | · | · | · | · | · | -1935.6% | · | -2378.6% | -2203.7% | -395.2% | -374.7% | · | |
| Pretax Margin | · | · | · | · | · | · | · | -2378.2% | -2203.3% | -394.7% | -369.9% | · | |
| EBITDA Margin | · | · | · | · | · | -1946.7% | · | -2397.1% | -2210.0% | -374.2% | 21.0% | · | |
| ROA | -82.9% | · | -81.8% | · | -105.3% | -77.2% | · | -51.7% | -48.7% | -43.1% | -22.6% | · | |
| ROE | -51.3% | · | -112.4% | · | -92.5% | -106.3% | · | -62.9% | -51.0% | -49.5% | -30.8% | · | |
| ROIC | -63.5% | · | -130.8% | · | · | · | · | -45.0% | -70.6% | -39.9% | · | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 10.7 | · | 3.5 | · | 8.3 | 5.3 | · | 21.6 | 21.1 | 19.4 | 4.1 | · | |
| Quick Ratio | 10.0 | · | 3.0 | · | 7.6 | 4.8 | · | 21.0 | 20.5 | 18.4 | 3.8 | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | · | · | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.1 | 0.1 | · | |
| Inventory Turnover | · | · | · | · | · | · | · | 0.9 | 1.6 | 2.0 | 2.0 | · | |
| Receivables Turnover | · | · | · | · | 0.0 | 2.2 | · | 10.0 | 5.2 | 10.4 | 7.5 | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.74 | · | $2.96 | · | $0.98 | $0.69 | · | $2.12 | $0.70 | $1.21 | $1.00 | · | |
| Revenue / Share | · | · | · | · | · | · | · | · | · | $0.14 | $0.10 | · | |
| Cash Flow / Share | · | · | · | · | · | · | · | · | · | $-0.51 | $-0.55 | · | |
| Cash / Share | $1.51 | · | $2.27 | · | $0.59 | $0.75 | · | $0.79 | $0.43 | $0.73 | $0.50 | · | |
| EPS (TTM) | · | · | · | · | · | · | · | · | · | $-0.57 | $-0.36 | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $110.0K | $110.0K | $110.0K | $110.0K | $0 | $328.8K | · | $211.8K | $228.3K | $1M | $758.7K | · | |
| Net Income TTM | $-7M | $-6M | $-8M | $-18M | $-13M | $-6M | · | $-5M | $-5M | $-5M | $-3M | · | |
| Market Cap | $18M | · | $10M | · | $687M | $543M | · | $311M | $3.49B | $7.15B | $15.02B | · | |
| P/E | · | · | · | · | · | · | · | · | · | -1237.9 | -5226.7 | · | |
| P/S | 160.4 | · | 95.4 | · | · | 1651.9 | · | 1469.0 | 15309.6 | 5624.1 | 19802.7 | · | |
| P/B | 1.4 | · | 1.5 | · | 52.6 | 81.9 | · | 27.6 | 472.4 | 580.8 | 1876.8 | · | |
| P / Tangible Book | 1.7 | · | 2.2 | 15.1 | 64.3 | 131.0 | · | · | · | · | · | · | |
| P / Cash Flow | -2.4 | · | -1.6 | · | -50.3 | -108.9 | · | -67.4 | -743.7 | -1587.4 | -3405.0 | · | |
| P / FCF | · | · | -1.6 | · | -50.2 | -108.8 | · | -62.3 | -698.7 | -1457.3 | -3205.5 | · | |
| Earnings Yield | · | · | · | · | · | · | · | · | · | -0.08% | -0.02% | · |
Income Statement
| Metric | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| R&D Expense | $4M | $3M | $1M | $1M | $939.1K | $484.3K | $1M | $103.9K | $897.3K | $1M | $704.5K | $953.4K | $1M | $1M | $1M | $2M | |
| SG&A Expense | $2M | $2M | $1M | $1M | $964.7K | $1M | $878.9K | $900.5K | $1M | $1M | $1M | $1M | $1M | $952.4K | $1M | $1M | |
| Operating Income | $-6M | $-4M | $-2M | $-2M | $-2M | $-2M | $-2M | $-1M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | |
| Other Non-op | $111.9K | $79.5K | $93.7K | $241.9K | $154.3K | $49.2K | $281.4K | $42.3K | $264.2K | $359.9K | $179.0K | $649.3K | $79.3K | $77.0K | $43.5K | $22.4K | |
| Pretax Income | $-5M | $-4M | · | $-2M | $-2M | $-2M | · | $-962.1K | $-2M | $-2M | · | $-2M | $-2M | $-2M | · | $-3M | |
| Income Tax | $0 | $800 | · | $0 | $0 | $800 | · | $0 | $0 | $800 | · | $0 | $0 | $800 | · | $0 | |
| Net Income | $-5M | $-4M | $-2M | $-2M | $-2M | $-2M | $-2M | $-962.1K | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-3M | |
| EPS (Basic) | $-0.60 | $-0.49 | $-0.28 | $-0.24 | $-0.25 | $-0.30 | $-0.48 | $-0.29 | $-0.52 | $-0.58 | $-0.54 | $-0.56 | $-0.68 | · | · | · | |
| Shares (Basic) | 9,007,474 | 8,541,146 | 7,972,532 | · | 7,022,678 | 5,305,763 | 3,345,135 | · | 3,221,806 | 3,192,688 | 3,128,024 | · | 2,930,681 | · | · | · | |
| EBITDA | $-6M | $-4M | $-2M | · | $-2M | $-2M | $-2M | · | $-2M | $-2M | $-2M | · | $-2M | $-2M | $-2M | · |
Balance Sheet
| Metric | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $10M | $10M | $12M | $11M | $12M | $14M | $2M | · | · | · | · | · | $6M | $7M | $8M | · | |
| Prepaid Expense | $219.7K | $197.6K | $234.4K | $77.8K | $112.7K | $108.2K | $157.8K | $367.4K | $454.7K | $330.3K | $404.9K | $448.9K | $414.0K | $608.1K | $690.9K | $745.5K | |
| Current Assets | $11M | $10M | $13M | $12M | $13M | $14M | $2M | $2M | $3M | $4M | $5M | $6M | $7M | $8M | $9M | $9M | |
| PP&E (Net) | · | · | · | · | · | · | · | · | $0 | $7.4K | $8.2K | $8.7K | $9.9K | $10.8K | $11.8K | $12.7K | |
| PP&E (Gross) | · | · | · | · | · | · | · | · | · | · | · | $52.5K | · | · | · | $52.2K | |
| Accum. Depreciation | · | · | · | · | · | · | · | · | · | · | · | $43.8K | · | · | · | $39.5K | |
| Intangibles | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | |
| Total Assets | $13M | $12M | $15M | $14M | $15M | $16M | $4M | $4M | $5M | $6M | $8M | $9M | $9M | $11M | $12M | $12M | |
| Accounts Payable | $4M | $2M | $756.2K | $1M | $672.7K | $914.7K | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $2M | |
| Current Liabilities | $4M | $2M | $756.2K | $1M | $672.7K | $914.7K | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $2M | |
| Capital Leases | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $19.8K | $40.1K | $64.4K | $76.6K | $0 | |
| Total Liabilities | · | · | · | · | · | · | · | · | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $2M | |
| Common Stock | $62M | $59M | $58M | $55M | $54M | $54M | $48M | $47M | $47M | $47M | $47M | $47M | $46M | $45M | $44M | · | |
| Paid-in Capital | $16M | $16M | $15M | $15M | $14M | $14M | $14M | $14M | $13M | $13M | $13M | $13M | $13M | $12M | $12M | $11M | |
| Retained Earnings | $-78M | $-72M | $-68M | $-66M | $-64M | $-62M | $-60M | $-59M | $-58M | $-56M | $-54M | $-52M | $-51M | $-49M | $-46M | $-44M | |
| AOCI | $-158.5K | $-186.1K | $-171.1K | $-165.8K | $-123.1K | $-287.7K | $-224.0K | $-242.6K | $-224.8K | $-226.4K | $-215.2K | $-214.6K | $-190.2K | $-230.0K | $-238.7K | $-213.6K | |
| Stockholders' Equity | $9M | $10M | $14M | $12M | $14M | $16M | $2M | $2M | $3M | $4M | $6M | $7M | $8M | $9M | $10M | $9M | |
| Liabilities + Equity | $13M | $12M | $15M | $14M | $15M | $16M | $4M | $4M | $5M | $6M | $8M | $9M | $9M | $11M | $12M | $12M | |
| Shares Outstanding | 9,633,223 | 8,885,719 | 8,333,823 | 7,141,783 | 7,022,678 | 7,022,678 | 3,467,658 | 3,247,389 | 3,247,389 | 3,215,968 | 3,164,722 | 3,075,473 | 20,866,772 | 20,058,665 | 19,353,351 | 2,380,280 |
Cash Flow
| Metric | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $25.6K | $25.9K | $25.5K | $25.9K | $25.8K | $24.5K | $43.1K | $44.2K | $51.4K | $45.4K | $45.0K | $46.0K | $83.0K | $27.3K | $27.2K | $29.0K | |
| Stock-based Comp | $547.5K | $484.9K | $399.9K | $404.4K | $177.4K | $66.7K | $81.2K | $93.9K | $109.5K | $149.7K | $184.4K | $517.1K | $108.2K | $287.5K | $333.7K | $456.0K | |
| Amort. of Intangibles | $30.0K | $30.0K | $30.0K | $101.17B | $30.0K | $30.0K | $30.0K | $101.17B | $30.0K | $30.0K | $30.0K | $101.17B | $30.0K | $30.0K | $30.0K | $1.01B | |
| Other Non-cash | · | · | $-265.0K | · | · | · | $-24.2K | · | · | · | · | · | · | · | · | · | |
| Operating Cash Flow | $-3M | $-2M | $-2M | $-2M | $-2M | $-2M | $-2M | $-967.0K | $-856.5K | $-2M | $-1M | $-1M | $-2M | $-2M | $-2M | $-6M | |
| CapEx | · | · | · | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $-41 | |
| Investing Cash Flow | · | · | · | · | · | · | · | · | · | · | $0 | · | $0 | $0 | $0 | $41 | |
| Stock Issued | $3M | $0 | $3M | $220.5K | $0 | $7M | $626.8K | $0 | $138.4K | $275.8K | $315.2K | $483.8K | $833.7K | $0 | $3M | $12M | |
| Net Stock Activity | · | · | $3M | · | · | · | $626.8K | · | · | · | $315.2K | · | · | · | · | · | |
| Financing Cash Flow | $3M | $-9.0K | $3M | $186.5K | $0 | $15M | $2M | $-31.4K | $106.0K | $211.7K | $305.7K | $412.5K | $741.2K | $764.6K | $3M | $-286 | |
| Net Change in Cash | $328.8K | $-2M | $1M | $-2M | $-2M | $12M | $526.2K | $-1M | $-758.7K | $-1M | $-1M | $-1M | $-1M | $-799.0K | $1M | $-6M | |
| Free Cash Flow | · | · | · | · | · | · | · | · | · | · | · | · | · | · | $-2M | · |
Profitability
| Metric | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ROA | -39.3% | -29.2% | -23.8% | · | -17.5% | -13.9% | -27.0% | · | -22.8% | -21.7% | -17.2% | · | -14.7% | -15.0% | -19.4% | · | |
| ROE | -47.1% | -32.8% | -27.7% | · | -20.6% | -16.0% | -39.9% | · | -31.1% | -27.9% | -20.8% | · | -20.2% | -17.9% | -22.4% | · | |
| ROIC | -62.6% | -42.1% | · | · | -13.5% | -10.5% | · | · | -67.4% | -51.4% | · | · | -26.3% | -26.8% | · | · |
Liquidity & Solvency
| Metric | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.8 | 4.8 | 16.8 | · | 19.0 | 15.7 | 1.1 | · | 1.3 | 2.0 | 2.7 | · | 4.5 | 5.2 | 7.1 | · | |
| Quick Ratio | 2.6 | 4.6 | 16.0 | · | 18.4 | 15.2 | 0.8 | · | · | · | · | · | 4.2 | 4.8 | 6.5 | · |
Per Share
| Metric | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $0.91 | $1.15 | $1.67 | · | $2.01 | $2.21 | $0.65 | · | $0.88 | $1.34 | $1.85 | · | $0.38 | $0.45 | $0.53 | · | |
| Cash / Share | $1.07 | $1.13 | $1.45 | · | $1.77 | $1.98 | $0.46 | · | · | · | · | · | $0.31 | $0.37 | $0.43 | · |
Valuation (TTM)
| Metric | Trend | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $500 | $500 | $500 | · | $500 | $500 | $500 | · | $500 | $500 | $500 | · | $500 | $500 | $500 | · | |
| Net Income TTM | $-14M | $-10M | $-8M | · | $-6M | $-6M | $-6M | · | $-7M | $-7M | $-8M | · | $-9M | $-13M | · | · | |
| Market Cap | $78M | $46M | $12M | · | $14M | $17M | $6M | · | $14M | $13M | $14M | · | $118M | $128M | $293M | · | |
| P/S | 156636.2 | 92944.6 | 23668.1 | · | 28512.1 | 34270.7 | 11651.3 | · | 27797.6 | 26949.8 | 28925.6 | · | 236629.2 | 255547.4 | 585245.3 | · | |
| P/B | 8.9 | 4.6 | 0.8 | · | 1.0 | 1.1 | 2.6 | · | 4.8 | 3.1 | 2.5 | · | 15.1 | 14.2 | 28.5 | · | |
| P / Tangible Book | 11.3 | 5.6 | 1.0 | · | 1.2 | 1.3 | 27.7 | · | 18.2 | 6.1 | 3.9 | · | 21.0 | 18.9 | 36.5 | · | |
| P / Cash Flow | · | · | -5.7 | · | · | · | -3.8 | · | · | · | -10.3 | · | · | · | -163.4 | · |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Revenue | · | · | · | · | $0 |
| Net Income | $-7M | $-6M | $-8M | $-18M | $-13M |
| Metric | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Current Ratio | 10.7 | · | 3.5 | · | 8.3 |
| Quick Ratio | 10.0 | · | 3.0 | · | 7.6 |
| Metric | 2025-09-30 | 2024-09-30 | 2023-09-30 | 2022-09-30 | 2021-09-30 |
|---|---|---|---|---|---|
| Free Cash Flow | · | · | $-7M | · | $-14M |
Institutional owners (13F) 35 filers · $29.8M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
35
Value held
$29.8M
New positions
11
Exited positions
6
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 11 (-4 vs prior Q) | 6 (0 vs prior Q) | 7 (+3 vs prior Q) | 5 (+3 vs prior Q) | +1.1M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| Velan Capital Investment Management LP | $6,727,575 | 827,500 | 22.57% | Shares |
| Rubric Capital Management LP | $5,443,035 | 669,500 | 18.26% | Shares |
| PERCEPTIVE ADVISORS LLC | $4,579,133 | 563,239 | 15.36% | Shares |
| MILLENNIUM MANAGEMENT LLC | $4,567,036 | 561,751 | 15.32% | Shares |
| Stonepine Capital Management, LLC | $3,190,807 | 456,439 | 10.71% | Shares |
| Boxer Capital Management, LLC | $1,666,650 | 205,000 | 5.59% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $665,351 | 81,839 | 2.23% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $657,586 | 80,879 | 2.21% | Shares |
| JANE STREET GROUP, LLC | $589,141 | 72,465 | 1.98% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $314,777 | 38,718 | 1.06% | Shares |
| STATE STREET CORP | $308,769 | 37,979 | 1.04% | Shares |
| XTX Topco Ltd | $287,412 | 35,352 | 0.96% | Shares |
| BlackRock, Inc. | $223,534 | 27,495 | 0.75% | Shares |
| NORTHERN TRUST CORP | $121,901 | 14,994 | 0.41% | Shares |
| SCOTIA CAPITAL INC. | $117,015 | 14,393 | 0.39% | Shares |
| TWO SIGMA INVESTMENTS, LP | $114,080 | 14,032 | 0.38% | Shares |
| UBS Group AG | $54,984 | 6,763 | 0.18% | Shares |
| VANGUARD GROUP INC | $54,520 | 37,600 | 0.18% | Shares |
| SBI Securities Co., Ltd. | $28,496 | 3,505 | 0.10% | Shares |
| Federation des caisses Desjardins du Quebec | $21,097 | 2,595 | 0.07% | Shares |
| ROYAL BANK OF CANADA | $15,000 | 1,851 | 0.05% | Shares |
| MCGUIRE CAPITAL ADVISORS INC | $12,195 | 1,500 | 0.04% | Shares |
| MORGAN STANLEY | $11,382 | 1,400 | 0.04% | Shares |
| Tower Research Capital LLC (TRC) | $10,000 | 1,230 | 0.03% | Shares |
| BNP PARIBAS FINANCIAL MARKETS | $9,122 | 1,122 | 0.03% | Shares |
| JPMORGAN CHASE & CO | $8,667 | 1,130 | 0.03% | Shares |
| Vanguard Global Advisers, LLC | $1,317 | 162 | 0.00% | Shares |
| TD Waterhouse Canada Inc. | $1,098 | 142 | 0.00% | Shares |
| Banque Cantonale Vaudoise | $1,000 | 3 | 0.00% | Shares |
| HRT FINANCIAL LP | $256 | 31,531 | 0.00% | Shares |
| JONES FINANCIAL COMPANIES LLLP | $66 | 8 | 0.00% | Shares |
| NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO | $33 | 4 | 0.00% | Shares |
| LRI Investments, LLC | $8 | 1 | 0.00% | Shares |
| DANSKE BANK A/S | $8 | 1 | 0.00% | Shares |
| AllSquare Wealth Management LLC | $2 | 1 | 0.00% | Shares |
Activists & 5%+ owners 8 positions
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Morgan Adam, VENKATARAMAN BALAJI, Velan Capital Holdings LLC, Velan Capital Investment Management LP, Velan Capital Management LLC, Velan Capital Master Fund LP, Velan Capital Opportunity Fund II LLC, Velan Horizon Fund LP, Velan Horizon GP LLC | Aug. 25, 2026 | 9.99% | Amendment | · | SEC |
| 1968160 Ontario Inc., Pardeep Nijhawan, Pardeep Nijhawan Medicine Professional Corporation, The Digestive Health Clinic Inc., The New Nijhawan Family Trust 2015 | Aug. 25, 2026 | 16.31% | Amendment | · | SEC |
| Pardeep Nijhawan Medicine Professional Corporation, The Digestive Health Clinic Inc., 1968160 Ontario Inc., The New Nijhawan Family Trust 2015, Pardeep Nijhawan ×11 filings | June 16, 2026 | 19.99% | Amendment | · | SEC |
| Velan Capital Master Fund LP, Velan Horizon Fund LP, Velan Capital Opportunity Fund II LLC, Velan Horizon GP LLC, Velan Capital Holdings LLC, Velan Capital Investment Management LP, Velan Capital Management LLC, Morgan Adam, VENKATARAMAN BALAJI ×2 filings | March 2, 2026 | 9.99% | Amendment | · | SEC |
| Lumira Capital II, L.P., Lumira Capital II (International), L.P., Lumira Capital GP, L.P., Lumira GP Inc., Lumira GP Holdings Co., Lumira Capital Investment Management Inc., Peter van der Velden, Benjamin Rovinski, Daniel Hetu, Gerald Brunk, Vasco Larcina ×4 filings | Jan. 13, 2023 | · | Initial filing | · | SEC |
| 10379085 Canada Inc., PCRI Inc., Morris Goodman, David Goodman, Gregory Orleski, Sonia Girolamo, Jean-Guy Goulet ×3 filings | Jan. 23, 2020 | · | Initial filing | Passive investment | SEC |
| Inveready Innvierte Biotech II, S.C.R. S.A., Josep Maria Echarri Torres ×2 filings | Sept. 10, 2019 | · | Initial filing | Passive investment | SEC |
| Frank R. Oakes ×4 filings | June 28, 2017 | · | Initial filing | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 25 insiders · 8 officers · 17 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Pardeep Nijhawan | Chief Executive Officer | Sept. 1, 2026 A | 899,100 | 8 | 0 | $229,882 |
| Peter J. Weiler | Chief Financial Officer | May 27, 2026 A | 129,609 | 0 | 0 | $0 |
| Stephen Lemieux | Chief Financial Officer | Aug. 4, 2023 A | 17,400 | 0 | 0 | $0 |
| Kathi Niffenegger | Chief Financial Officer | Nov. 2, 2022 A | 10,715 | 0 | 0 | $0 |
| Michael J Brooks | President | May 27, 2026 A | 291,479 | 1 | 0 | $3,140 |
| Mary Catherine Brisson | Chief Operating Officer | Dec. 22, 2015 A | · | 0 | 0 | $0 |
| Gregory T. Baxter | EVP, Corporate Development | March 12, 2018 A | · | 0 | 0 | $0 |
| Mark A. Mcpartland | Title: Vice President, Corporate Development and Communications | Dec. 22, 2015 A | · | 0 | 0 | $0 |
| Da David Liu | Director | May 27, 2026 A | 24,501 | 0 | 0 | $0 |
| Joan Chypyha | Director | May 27, 2026 A | 30,029 | 0 | 0 | $0 |
| Marshall Patrick | Director | May 27, 2026 A | 71,666 | 0 | 0 | $0 |
| Sean Arthur Macdonald | Director | May 27, 2026 A | 41,054 | 0 | 0 | $0 |
| Carlo Sistilli | Director | May 27, 2026 A | 49,417 | 0 | 0 | $0 |
| Charles V Olson | Director | May 27, 2026 A | 30,000 | 0 | 0 | $0 |
| Frank R. Oakes | Director | July 20, 2023 A | 0 | 0 | 0 | $0 |
| Jennifer M Chao | Director | March 28, 2022 A | · | 0 | 0 | $0 |
| Paul William Pay | Director | Feb. 28, 2022 A | 3,654 | 0 | 0 | $0 |
| Lorin K Johnson | Director | Feb. 28, 2022 A | 12,786 | 0 | 0 | $0 |
| Peter Van Der Velden | Director | April 22, 2021 A | · | 0 | 0 | $0 |
| Deborah F. Aghib | Director | March 12, 2019 A | · | 0 | 0 | $0 |
| Paul Chun | Director | March 12, 2019 A | · | 0 | 0 | $0 |
| David Louis Hill | Director | March 12, 2019 A | · | 0 | 0 | $0 |
| Mayank D. Sampat | Director | March 12, 2019 A | · | 0 | 0 | $0 |
| Tessie M Che | Director | March 12, 2019 A | · | 0 | 0 | $0 |
| Daniel E. Morse | · | Oct. 12, 2018 S | 20,741 | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 1 ETF
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
| Fund | Weight | Units | As of | Source |
|---|---|---|---|---|
| VXF · VANGUARD INDEX FUNDS | 0.00% | 81,839 SH | Aug. 19, 2026 | Daily |
EDSA Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 9 analysts
BUY
Median target
$19.00
+392.2%
2 22.2%
Strong Buy
6 66.7%
Buy
1 11.1%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
12-Month Price Target
3 analysts · 2026-09-30Mean target $16.33 +323.1%
← Below all targets
Current price $3.86
Low$9.00
Mean$16.33
High$21.00
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 10-Q filed Aug 13, 2026